A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis
Clinical trial NCT01194414 · COMPLETED
Trial details
- NCT number
- NCT01194414
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-01-01
- Enrollment
- 1262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.